Evidence map›Paper›PMID 16772783›Full record

Trial reportAnnals of surgery2006

Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients.

Rene Przkora, David N Herndon, Oscar E Suman, Marc G Jeschke, Walter J Meyer, David L Chinkes, Ronald P Mlcak, Ted Huang, Robert E Barrow

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of surgery, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Recombinant human growth hormone for treating burns and donor sites.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Predictors of muscle protein synthesis after severe pediatric burns.The journal of trauma and acute care surgery · 2015
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Glucose Metabolism in Burns-What Happens?International journal of molecular sciences · 2021
    Review
  8. Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.Burns : journal of the International Society for Burn Injuries · 2020
    Review
  9. Review
  10. Cardiovascular Effect of Varying Interval Training Frequency in Rehabilitation of Severely Burned Children.Journal of burn care & research : official publication of the American Burn Association · 2019
    Article
  11. The Long-Term Impact of Severe Burn Trauma on Musculoskeletal Health.Journal of burn care & research : official publication of the American Burn Association · 2018
    Review
  12. Review
  13. Article
  14. The biochemical alterations underlying post-burn hypermetabolism.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  15. Observational
  16. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Article
  17. Article
  18. Review
  19. Review
  20. Burns in children: standard and new treatments.Lancet (London, England) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rene PrzkoraDepartment of Surgery, University of Texas Medical Branch and Shriners Hospitals for Children, 815 Market Street, Galveston, TX 77550, USA.
David N Herndon
Oscar E Suman
Marc G Jeschke
Walter J Meyer
David L Chinkes
Ronald P Mlcak
Ted Huang
Robert E Barrow
Shriners Hospitals for Children - Galveston · US

Funding

Project 9: The role of androgen/corticosteroid in fat, muscle and glucose metabolism of burn victimsP50GM060338 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SZABO, CSABA · 2000 to 2017
$24.2M
POSTDOCTORAL TRAINING IN TRAUMA &BURNST32GM008256 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Celeste Campbell Finnerty, Oscar E. Suman-Vejas · 1990 to 2026
$4.0M
NIGMS NIH HHS P50 GM060338NIGMS NIH HHS P50 GM 60338-06NIGMS NIH HHS T32 GM008256NIGMS NIH HHS T32 GM 08256-15PHS HHS H133A 020102-05
6 · The paper itself

Abstract

objectiveTo study the efficacy of growth hormone given to severely burned children from discharge to 12 months after burn and for 12 months after the drug was discontinued. SUMMARY BACKGROUND DATA: We have previously shown that low-dose recombinant human growth hormone (rhGH), given to children after a severe thermal injury, successfully improved lean muscle mass, bone mineral content, and growth. The aim of the present study was to investigate long-term functional improvements after treatment.

methodsForty-four pediatric patients with over 40% total body surface area burns were studied for 24 months after burn. Patients were randomized to receive either rhGH (0.05 mg/kg body weight) or placebo. Height, weight, body composition, serum hormones, resting energy expenditure, cardiac function, muscle strength, and number of reconstructive procedures performed were measured during rhGH treatment and for 12 months after treatment was discontinued. Statistical analysis used Tukey's multiple comparison test. Significance was accepted at P < 0.05.

resultsHeight, weight, lean body mass, bone mineral content, cardiac function, and muscle strength significantly improved during rhGH treatment compared with placebo (P < 0.05). This treatment significantly increased GH, IGF-I, and IGFBP-3, whereas serum cortisol decreased (P < 0.05). The number of operative reconstructive procedures was significantly lower with rhGH (P < 0.05). Improvements in height, bone mineral content, and IGF-1 concentrations persisted after rhGH treatment (P < 0.05). No side effects with rhGH were observed.

conclusionsAdministration of rhGH for 1 year after burn was safe and improved recovery. These salutary effects continued after rhGH treatment was discontinued.

Indexed as

OutpatientsBurnsChildDouble-Blind MethodFemaleFollow-Up StudiesHuman Growth HormoneHumansMalePatient DischargeRecombinant ProteinsRetrospective StudiesTime FactorsTrauma Severity IndicesTreatment OutcomeVentricular Function, LeftHuman Growth HormoneRecombinant Proteins

Identifiers

PMID16772783
PMCPMC1479605
OpenAlexW2090223941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.